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Supplementary tables 
Table S1. Accuracy of gene prediction. Accuracy of gene prediction on an O. degus 
“artificial scaffold” consisting of 238 concatenated O. degus test sequences (with 800 
nucleotides of sequence between each of the gene models) using the ab initio programs 
geneid, AUGUSTUS and SNAP with their pre-existing Mammalian/H. sapiens parameter 
files (i.e. “mam/hs”). The accuracy of SGP2 (homology evidence-based prediction tool that 
used the genome of H. sapiens as reference) and that of Augustus (using RNASeq and 
transcript evidence i.e. “AUGUSTUS+hints”) were also tested for accuracy on the same 
set of sequences. Geneid (geneid+introns) and SGP2 (SGP2+introns) using introns as 
external evidence were also evaluated. (SN & SP: sensitivity & specificity at nucleotide 
level; SNe & SPe: sensitivity & specificity at exon level; SNg & SPg: sensitivity & specificity 
at gene level). 
 
Program/param SN SP SNe SPe SNg SPg 
Geneid man/hs 0.83 0.75 0.65 0.69 0.09 0.06 
Geneid+intron mam/hs 0.92 0.82 0.83 0.79 0.24 0.17 
SGP2 odegus / Hs 0.90 0.82 0.77 0.73 0.12 0.08 
SGP2+intron odegus / mam/hs 0.95 0.86 0.86 0.79 0.26 0.17 
Augustus+hints mam/hs 0.87 0.94 0.81 0.90 0.33 0.35 
Augustus mam/hs 0.81 0.84 0.68 0.75 0.06 0.07 
SNAP mam/hs 0.83 0.45 0.57 0.32 0.03 0.01 
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Table S2. Weights used by EVM to create a consensus CDS model O. degus. The 
shortcuts interpretation: SPLAN2 uniprot90: SPLAN2 search against Uniprot90 proteins; 
SPALN2 uniprot-swissprot: SPALN2 against rodent uniprot/swissprot curated proteins; 
Exonerate uniprot-swissprot: exonerate against against rodent uniprot/swissprot curated 
proteins; 
 
Type Source Weight 
ABINITIO_PREDICTION Augustus 1 
ABINITIO_PREDICTION AugustusHints 1.75 
ABINITIO_PREDICTION geneid 1 
ABINITIO_PREDICTION SGP2 1.25 
ABINITIO_PREDICTION geneid+introns 1.5 
ABINITIO_PREDICTION SGP2+introns 1.75 
ABINITIO_PREDICTION SNAP 0.3 
PROTEIN SPALN2 uniprot90 5 
PROTEIN SPALN2 uniprot-swissprot 4 
PROTEIN exonerate uniprot-swissprot 4 
TRANSCRIPT PASA 10 
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Table S3. Comparison between EVM-based and GNOMON-based protein coding 
gene annotation. Statistics for two protein-coding annotations for O. degus.  
 
Annotation versions 
O.degus 2a (EVM-
generated) 
O.degus (ncbi 
GNOMON) -protein-
coding only- 
Genome length (Mbases) 2,995.89 
 
number of scaffolds 7,134 
 
Number of protein-coding genes 31,739 20,779 
Gene density (genes/Kbase) 0.0106 0.007 
Number of protein-coding transcripts 36,866 26,248 
Transcripts/gene (range) (% genes 
with more than 1 transcript) 
1.16 (SD 0.72) (1 – 
32) (9.24%)  
1.26 (SD 0.94) (1 – 
31)(15%) 
Number of transcripts with UTRs 10,648 - 
Number of proteins 36,575 26,248 
Number of complete proteins (%) 33,858 (92.57%) - 
Number/(%) proteins with similarity to 
sequences in the NCBI NR database 
(E=10-2; min. identity=25%) 
35,475 (97%) - 
Avg. length of proteins (range) 461.96 aa. (SD 
593.73) (25 – 
34,458) 
577.56 aa. (SD 641.03) 
(23 – 34,357) 
Avg. length of full-length proteins 
(range) 
478.57 aa. (SD 
602.27) (25 – 
34,458) 
- 
Number of partial proteins (not starting 
with "M") 
1842 (5.04%) 259 (0.98%) 
Avg. length of partial proteins (not 
starting with "M") 
253.11 aa. (SD 
431.8) 
- 
Number of partial proteins (no terminal 
STOP codon) 
1589 (4.34%) 
(can’t determine as 
gnomon protein set 
has no clear STOP 
signal) 
Avg. length of partial proteins (no 213.91 aa. (SD - 
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terminal STOP codon) 350.85) 
Number of partial proteins (not starting 
with an M -and- no terminal STOP 
codon) 
714 (1.95%) - 
Avg. length of partial proteins (not 
starting with an M -and- no terminal 
STOP codon) 
158.83 aa. (SD 
261.08) 
- 
Number of partial proteins (not starting 
with an M -or- no terminal STOP 
codon) 
2,717 (7.43%) - 
Avg. length of partial proteins (not 
starting with an M -or- no terminal 
STOP codon) 
254.96 aa. (SD 
423.14) 
- 
Number of protein-coding exons 288,884 268,660 
Number of introns 252,018 242,412 
Number of UTRs (spliced) 19,003 - 
Number of single-exon genes 10,114 3,156 
Number of multi-exonic transcripts 
(genes) 
26,752 (21,740) 23,092 (17,623) 
Exons/transcript (range) (excludes 
single-exon genes)  
10.42 (SD 10.50) (2 
– 313) 
11.49 (SD 10.35) (2 – 
313) 
Introns/transcript  (range) 9.42 (SD 10.50) (1 – 
312) 
10.49 (SD 10.35) (1 – 
312) 
“spliced” UTRs/transcript (range) 1.785 (SD 0.74) (1 - 
5) 
- 
Avg. length of introns (range) 5,998 (SD 19,994.1) 
(21 – 734,060) 
5,613.03 (SD 19,909.6) 
(30 – 1,116,408) 
Avg. length of mono-exonic genes 519.27 (SD 430.56) 872.88 (SD 618.70) 
Avg. length of exons (excludes mono-
exonic genes)  
165.37 (SD 233.34)  161.25 (SD 230.37)  
Avg. length of first exons 230.78 (SD 336.07) - 
Avg. length of internal exons 149.24 (SD 194.59) - 
Avg. length of terminal exons 235.72 (SD 352.41) - 
Avg. length of CDS (range) 1,392.9 (SD 
1,782.42) (75  – 
1,736.06 (SD 1,923.46) 
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103,074) (69 – 103,074) 
Avg. length of UTRs (range) 653.40 (SD 942.07) 
(1 - 11,857) 
- 
Avg. length of primary transcripts  43,714.8 (SD 
107,530)  
56,055.1 (SD 117,349) 
G+C content exonic (mono-exonic 
genes) 
49.72% (SD 7.63%) 51.85% (SD 8.56%) 
G+C content exonic (excludes mono-
exonic genes) 
52.53% (SD 7.47%) 53.52% (SD 7.42%) 
G+C content exonic (first exons) 53.62% (SD 
10.85%) 
- 
G+C content exonic (internal exons) 51.27% (SD 9.67%) - 
G+C content exonic (terminal exons) 53.59% (SD 
10.84%) 
- 
G+C content intronic 45.05% (SD 
11.54%) 
45.45% (SD 11.61%) 
G+C content genomic 40.16% (SD 5.63%) 
G+C content UTRs 53,76% (SD 5%) - 
 
 
 
7 
 
Table S4.  Non-default parameters for RNA-seq mappings. Non-default parameters 
used during mapping step of pair-end reads of human brain AD subjects and control 
samples with STAR 2.4.0.1. First column refers to the name of the parameter, while the 
second to its value. 
Parameter Value 
outSAMunmapped Within 
outFilterType BySJout 
outFilterMultimapNmax 20 
outFilterMismatchNmax 999 
outFilterMismatchNoverReadLmax 0.04 
alignIntronMin 20 
alignIntronMax 1000000 
alignSJDBoverhangMin 1 
readFilesCommand zcat 
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Supplementary Table S5. Functional annotation statistics. Abbreviature KO – KEGG 
orthology groups. 
Number of proteins/genes 36,575 / 31,739 
Annotated proteins/genes 34,571 (94.5%) / 30,336 (95.5%) 
Proteins with Interpro signatures  33,800 (92.4%) 
Proteins with Blast2GO or KEGG definition 23,936 (65.4%) 
Proteins with Blast2GO definition 16,737 (45.7%) 
Proteins with KEGG definition  14,756 (40.3%) 
Proteins assigned to KO groups 14,879 (40.6%) 
Proteins with GO terms association 28,988 (79.2%) 
Conserved domains signatures 31,874 (87.1%) 
Conserved features signatures 15,017 (41%) 
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Supplementary Table S6. GO term annotation.  A. Number of GO terms associated to 
each ontology B. Top 10 GO terms more frequently associated to proteins grouped by GO 
term type. 
A. 
Term type Number of proteins 
Biological process 22,200 
Cellular component 20,110 
Molecular function 27,220 
All 29,847 
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B 
GO term id GO term description # Proteins 
 Biological process  
GO:0006412 translation 2938 
GO:0006355 regulation of transcription, DNA-templated 1865 
GO:0007186 G-protein coupled receptor signaling pathway 1505 
GO:0006414 translational elongation 1073 
GO:0055114 oxidation-reduction process 1016 
GO:0006413 translational initiation 904 
GO:0007165 signal transduction 902 
GO:0006468 protein phosphorylation 882 
GO:0000184 
nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
830 
GO:0006614 
SRP-dependent cotranslational protein targeting to 
membrane 
823 
 Molecular function  
GO:0005515 protein binding 6905 
GO:0003735 structural constituent of ribosome 3023 
GO:0005524 ATP binding 2431 
GO:0003676 nucleic acid binding 2166 
GO:0008270 zinc ion binding 1982 
GO:0000166 nucleotide binding 1785 
GO:0003677 DNA binding 1755 
GO:0046872 metal ion binding 1706 
GO:0004930 G-protein coupled receptor activity 1311 
GO:0003723 RNA binding 1280 
 Cellular component  
GO:0005622 intracellular 3658 
GO:0005634 nucleus 3517 
GO:0016021  integral component of membrane  3502 
GO:0005840 ribosome 2927 
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GO:0005737 cytoplasm 2338 
GO:0016020 membrane 2165 
GO:0005829 cytosol 1641 
GO:0005886 plasma membrane 1487 
GO:0005730 nucleolus 1429 
GO:0022625 cytosolic large ribosomal subunit 1007 
 
 
 
 
 
 
12 
 
Table S7. GO-terms enrichment for differentially expressed genes in O. degus. 
Biological processes overrepresented by up- and down-regulated genes identified in O. 
degus brain samples. GO terms shown are those significantly overrepresented (pvalue < 
0.05) by genes showing differential expression between AD-like subjects and controls. 
Categories are sorted by p-value. 
 
 
TABLE IN ADDITIONAL FILE 2 
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Table S8. GO terms enrichment for differentially expressed genes in human 
samples. Biological processes overrepresented by up- and down-regulated genes 
identified in human brain samples. GO terms shown are those significantly 
overrepresented (pvalue < 0.05) by genes showing differential expression between AD 
subjects and controls. Categories are sorted by p-value. 
 
TABLE IN ADDITIONAL FILE 2 
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Table S9. Genes differentially expressed between human samples. The complete list 
of 2963 human genes displaying differential expression between AD subjects and controls. 
Genes are ranked by FDR (FDR < 0.05). 
TABLE IN ADDITIONAL FILE 2 
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Table S10. Pairwise comparisons to measure the gene expression level differences 
between AD-like degus and controls. 
 
TABLE IN ADDITIONAL FILE 2 
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Supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. Gene ontology mapping of O. degus genes. The GO terms were mapped 
into the general GO slims without top level categories – biological process, molecular 
function, cellular component. 
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Figure S2. Distribution of functionally annotated and non-annotated proteins. 
Number of annotated and non-annotated sequences in relation to their length. The blue 
color correspond to all proteins, red – annotated proteins and green to the non-annotated 
proteins. 
 
 
 
